BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 38654930)

  • 1. Association between metabolic syndrome and the risk of colorectal cancer: a prospective study in China.
    Wang Z; Chen R; Zhang L; Chen Y; Li J; Li S; Xu L; Hu Y; Bai Y
    Eur J Cancer Prev; 2024 Jul; 33(4):347-354. PubMed ID: 38375832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between lower extremity function and cardiovascular diseases risk in older Chinese adults: Longitudinal evidence from a nationwide cohort.
    Feng S; Wang J; Yin C; Li H; Wang T; Liu J; Liang Y; Liu J; Han D
    Arch Gerontol Geriatr; 2024 Sep; 124():105463. PubMed ID: 38723574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological aging mediates the associations of metabolic score for insulin resistance with all-cause and cardiovascular disease mortality among US adults: A nationwide cohort study.
    Li X; Wang J; Zhang M; Li X; Fan Y; Zhou X; Sun Y; Qiu Z
    Diabetes Obes Metab; 2024 Jun; ():. PubMed ID: 38853301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of metabolic syndrome score trajectory patterns with risk of all cancer types.
    Deng L; Liu T; Liu CA; Zhang Q; Song MM; Lin SQ; Wang YM; Zhang QS; Shi HP
    Cancer; 2024 Jun; 130(12):2150-2159. PubMed ID: 38462898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heritability of the Severity of the Metabolic Syndrome in Whites and Blacks in 3 Large Cohorts.
    Musani SK; Martin LJ; Woo JG; Olivier M; Gurka MJ; DeBoer MD
    Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28408709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The circadian syndrome is a predictor for cognition impairment in middle-aged adults: Comparison with the metabolic syndrome.
    Shi Z; Stern N; Liu J; Tuomilehto J; Kronfeld-Schor N; El-Osta A; Alberti G; Chai Z; Bilu C; Einat H; Marcus Y; Zimmet P
    Diabetes Metab Res Rev; 2024 Jul; 40(5):e3827. PubMed ID: 38837323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mediating effect of sleep duration on metabolic syndrome severity in adults: a structural equation modeling approach.
    Hemati N; Satari S; Khazaie H; Salimi Y; Najafi F; Pasdar Y; Darbandi M
    BMC Endocr Disord; 2024 May; 24(1):75. PubMed ID: 38807076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal dysfunction, metabolic syndrome and cardiovascular disease mortality.
    Martins D; Ani C; Pan D; Ogunyemi O; Norris K
    J Nutr Metab; 2010; 2010():. PubMed ID: 20700408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic Syndrome for Cardiovascular Disease Morbidity and Mortality Among General Japanese People: A Mini Review.
    Watanabe J; Kotani K
    Vasc Health Risk Manag; 2020; 16():149-155. PubMed ID: 32368073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between metabolic syndrome severity score and cardiovascular disease: results from a longitudinal cohort study on Chinese adults.
    Lin JJ; Dai PY; Zhang J; Guan YQ; Gong WW; Yu M; Fang L; Hu RY; He QF; Li N; Wang LX; Liang MB; Zhong JM
    Front Endocrinol (Lausanne); 2024; 15():1341546. PubMed ID: 38654930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous metabolic syndrome severity score and the risk of CVD and all-cause mortality.
    Tang X; Wu M; Wu S; Tian Y
    Eur J Clin Invest; 2022 Sep; 52(9):e13817. PubMed ID: 35598176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the baseline insulin resistance surrogates and their longitudinal trajectories on cardiovascular disease (coronary heart disease and stroke): a prospective cohort study in rural China.
    Wang S; Zhang X; Keerman M; Guo H; He J; Maimaitijiang R; Wang X; Ma R; Guo S
    Front Endocrinol (Lausanne); 2023; 14():1259062. PubMed ID: 38189050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
    Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
    Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
    Ramezankhani A; Azizi F; Hadaegh F
    Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.